West Chester, PA, United States of America

Robert Prybolsky


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Robert Prybolsky in Statin Medication Delivery

Introduction

Robert Prybolsky is an accomplished inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceutical delivery systems, particularly focusing on statin medications. With a total of 2 patents to his name, Prybolsky's work aims to enhance patient access to essential medications.

Latest Patents

Prybolsky's latest patents include innovative systems and methods for dispensing statin medications over the counter. The first patent outlines a process where survey results from a subject are evaluated against a series of filters. If a filter is triggered, the subject is deemed unqualified for the medication. Conversely, if the subject qualifies, they receive a drug facts label and can confirm their understanding before the medication is dispensed. The second patent focuses on treating atherosclerotic cardiovascular disease by administering statin pharmaceutical compositions to qualified subjects. This method includes various active ingredients such as atorvastatin and simvastatin, ensuring that patients receive appropriate treatment.

Career Highlights

Prybolsky is currently employed at AstraZeneca U.K. Limited, where he continues to develop innovative solutions in the pharmaceutical industry. His work is pivotal in making statin medications more accessible to patients who need them.

Collaborations

Prybolsky collaborates with talented colleagues, including James Blasetto and Judy Firor, who contribute to the development and refinement of his innovative ideas.

Conclusion

Robert Prybolsky's contributions to the field of statin medication delivery demonstrate his commitment to improving patient care. His innovative patents reflect a deep understanding of both pharmaceutical needs and patient accessibility.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…